24.5.2017
Organized by ESSEC Business School, Asia-Pacific and Biotech Connection Singapore, the Health, Business and Society (HBS) Public Talk, "From Clinical Needs to Market: Challenges to Commercialization" will be held on Wednesday, 7 June 2017.
The HBS Public Talk series was initiated with the aim of facilitating and disseminating insights to relevant stakeholders in the industry, so as to deliver meaningful recommendations to both public and private policy decision makers.
To register for the talk, kindly drop us a message at essecasia@essec.edu.
Abstract
Biomedical innovation is poised to become a key pillar for Singapore's future economy, in areas ranging from biopharmaceuticals, digital health solutions, to diagnostics and medical devices. However, the commercialization of life science technologies is especially long and bumpy, with high chances of failure. How do budding entrepreneurs manage such risks and develop successful go-to market strategies? How do we prioritise the market segments to focus on, and figure out the best way to engage clinicians and payers?
Join us for the next Health, Business and Society Public Talk and explore the perspectives of our experienced panelists, including successful entrepreneurs and industry leaders from public and private sectors.
Event Details
Date and Time: Wednesday, 7 June 2017 | 7:30pm - 9:30pm
Venue: ESSEC Business School, Asia-Pacific, 5 Nepal Park, Singapore 139408
Panelists
Mr. Amkidit AFABLE Director, Go-to-Market Strategies, Johnson & Johnson |
Mr. David BARDA Vice President, Medical Technologies Cluster, Biomedical Sciences Division at Exploit Technologies Pte Ltd |
Dr. Snehal PATEL Co-Founder, MyDoc |
Moderator
Mr. Joe CAPUTO Associate Director, IHEM Asia-Pacific, ESSEC Business School |